Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome

Table 2 Laboratory values at initial and last follow up in the individual groups of patients with viral hepatitis and primary biliary cirrhosis (mean ± SD)

Laboratory tests	PBC + HCV(n = 8)	PBC + HBV(n = 9)
Bilirubin initial (mg/dL)	1.0 ± 0.4	1.8 ± 1.7
Bilirubin last	4.3 ± 6.8	2.8 ± 5.8
Albumin initial(gr/dL)	3.8 ± 1.0	4.2 ± 0.7
Albumin last	3.5 ± 0.8	4.1 ± 0.7
PT initial (s)	14.5 ± 4.1	13.6 ± 1.8
PT last	14.8 ± 5.2	12.3 ± 1.4
ALT initial (IU/L)	88 ± 91	82 ± 131
ALT last	48 ± 37	27 ± 12
AST initial (IU/L)	74 ± 64	77 ± 98
AST last	53 ± 29	42 ± 38
γ GT initial (IU/L)	92 ± 139	76 ± 95
γ GT last	47 ± 49	29 ± 16
ALP initial (IU/L)	100 ± 29	106 ± 90
ALP last	93 ± 35	90 ± 33
IgG initial (mg/dL)	1764 ± 470	1815 ± 762
IgG last	2133 ± 612	1420 ± 392
IgM initial (mg/dL)	161 ± 69	281 ± 312
IgM last	264 ± 334	251 ± 186

PBC: Primary biliary cirrhosis; PT: Prothrombine time; ALT: Alanine amonitransferase; AST: Aspartate aminotransferase; γ-GT: Gamma-glutamyl-transpeptidase; ALP: Alkaline phosphatase; HBV: Hepatitis B virus; HCV: Hepatitis C virus.